Skip to main content

Tarsus Pharmaceuticals, Inc.

TARS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001819790

In the last 90 days, Tarsus Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 6 sales; 256 institutions reported holding it in 13F filings for Q2 2026, worth $2.98B in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Tarsus Pharmaceuticals, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
6 filings
4 insiders, $5.19M in total
Insiders trading
4
Net value
−$5.19M
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Tarsus Pharmaceuticals, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Tarsus Pharmaceuticals, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Pyott David E IDirector9,575IndirectSep 17, 20264
Yarno Wendy LDirector16,956Sep 17, 20263
Link William J PhDDirector94,487Sep 17, 20266
Azamian Bobak R.President/CEO and Board Chair827,991IndirectSep 9, 20268
Lin Elizabeth YeuChief Medical Officer1,590IndirectSep 9, 20266
Neervannan SeshadriChief Operating Officer78,532Sep 9, 20267
Chaudhuri BhaskarDirector11,654Jun 29, 20262
Morrison Scott WDirector7,638Jun 29, 20262
Goldberg Andrew D.Director19,654Jun 29, 20262
Goodrich KatherineDirector2,233Jun 29, 20264
Farrow Jeffrey SSee Remarks56,801Jun 17, 20264
Mottiwala AzizChief Commercial Officer61,480Mar 19, 20263
Whitfield Dianne C.Chief Human Resources Officer35,028Mar 19, 20265
Wahl BryanGeneral Counsel63,959Mar 19, 20263
Crane Rosemary ADirector5,350Jun 25, 20240
Trevejo Jose M.CHIEF MEDICAL OFFICER2,251Dec 22, 20230
Greenstein Leonard M.Chief Financial Officer26,785Apr 21, 20230
Holdbrook Mark J.V.P., Clinical Affairs3,191Mar 21, 20230
Ackermann MichaelDirector1,208,273Jul 1, 20220
Vivo Capital Fund IX, L.P.10% Owner2,469,001IndirectMay 5, 20220
Vivo Capital IX, LLC10% Owner2,469,001IndirectMay 5, 20220

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Feb 10, 2023 (view filing)Feb 82 daysAzamian Bobak R.President/CEO and Board ChairSSale−9.00K$15.14−$136.3K−0.8%1.10M after
Feb 17, 2023 (view filing)Feb 161 dayGreenstein Leonard M.Chief Financial OfficerSSale−5.00K$15.12−$75.6K−12.7%34.3K after
Feb 17, 2023 (view filing)Feb 152 daysAzamian Bobak R.President/CEO and Board ChairSSale−8.00K$15.28−$122.2K−0.7%1.09M after
Mar 10, 2023 (view filing)Mar 8-92 daysAzamian Bobak R.President/CEO and Board ChairSSale−5.57K$15.02−$83.7K−0.5%1.09M after2 lots
Mar 17, 2023 (view filing)Mar 161 dayNeervannan SeshadriChief Operating OfficerSSale−357$13.43−$4.79K−0.6%56.6K after
Mar 17, 2023 (view filing)Mar 161 dayMottiwala AzizChief Commercial OfficerSSale−336$13.43−$4.51K−0.6%54.6K after
Mar 17, 2023 (view filing)Mar 161 dayTrevejo Jose M.Chief Medical OfficerSSale−499$13.43−$6.70K−5.5%8.65K after
Mar 17, 2023 (view filing)Mar 161 dayWhitfield Dianne C.Chief Human Resources OfficerSSale−313$13.43−$4.20K−2.4%12.9K after
Mar 17, 2023 (view filing)Mar 161 dayWahl BryanGeneral CounselSSale−337$13.43−$4.53K−1.8%18.2K after
Mar 17, 2023 (view filing)Mar 161 dayHoldbrook Mark J.V.P., Clinical AffairsSSale−187$13.43−$2.51K−5.0%3.58K after
Mar 17, 2023 (view filing)Mar 161 dayGreenstein Leonard M.Chief Financial OfficerSSale−5.31K$13.44−$71.4K−13.7%33.4K after2 lots
Mar 17, 2023 (view filing)Mar 152 daysAzamian Bobak R.President/CEO and Board ChairSSale−8.00K$13.79−$110.3K−0.7%1.08M after
Mar 17, 2023 (view filing)Mar 161 dayAzamian Bobak R.President/CEO and Board ChairSSale−791$13.43−$10.6K−6.1%12.3K after
Mar 21, 2023 (view filing)Mar 17-204 daysGreenstein Leonard M.Chief Financial OfficerSSale−649$12.94−$8.40K−1.9%32.8K after2 lots
Mar 21, 2023 (view filing)Mar 17-204 daysTrevejo Jose M.CHIEF MEDICAL OFFICERSSale−1.03K$12.94−$13.4K−11.9%7.62K after2 lots
Mar 21, 2023 (view filing)Mar 17-204 daysMottiwala AzizChief Commercial OfficerSSale−697$12.94−$9.02K−1.3%53.9K after2 lots
Mar 21, 2023 (view filing)Mar 17-204 daysHoldbrook Mark J.V.P., Clinical AffairsSSale−386$12.94−$4.99K−10.8%3.19K after2 lots
Mar 21, 2023 (view filing)Mar 17-204 daysNeervannan SeshadriChief Operating OfficerSSale−740$12.94−$9.57K−1.3%55.8K after2 lots
Mar 21, 2023 (view filing)Mar 17-204 daysAzamian Bobak R.President/CEO and Board ChairSSale−1.54K$12.96−$19.9K−12.5%10.7K after2 lots
Mar 21, 2023 (view filing)Mar 17-204 daysWhitfield Dianne C.Chief Human Resources OfficerSSale−649$12.94−$8.40K−5.0%12.2K after2 lots
Mar 21, 2023 (view filing)Mar 17-204 daysWahl BryanGeneral CounselSSale−696$12.94−$9.00K−3.8%17.5K after2 lots
Mar 23, 2023 (view filing)Mar 21-232 daysGreenstein Leonard M.Chief Financial OfficerSSale−1.00K$12.55−$12.6K−3.1%31.8K after3 lots
Mar 23, 2023 (view filing)Mar 21-232 daysTrevejo Jose M.CHIEF MEDICAL OFFICERSSale−1.51K$12.58−$19.0K−19.9%6.11K after3 lots
Mar 23, 2023 (view filing)Mar 21-232 daysMottiwala AzizChief Commercial OfficerSSale−1.08K$12.55−$13.5K−2.0%52.8K after3 lots
Mar 23, 2023 (view filing)Mar 21-232 daysNeervannan SeshadriChief Operating OfficerSSale−1.14K$12.55−$14.3K−2.0%54.7K after3 lots
Mar 23, 2023 (view filing)Mar 21-232 daysAzamian Bobak R.President/CEO and Board ChairSSale−2.13K$12.55−$26.7K−19.8%8.60K after3 lots
Mar 23, 2023 (view filing)Mar 21-232 daysWhitfield Dianne C.Chief Human Resources OfficerSSale−1.00K$12.55−$12.6K−8.2%11.2K after3 lots
Mar 23, 2023 (view filing)Mar 21-232 daysWahl BryanGeneral CounselSSale−1.08K$12.55−$13.5K−6.2%16.4K after3 lots
Apr 21, 2023 (view filing)Apr 201 dayGreenstein Leonard M.Chief Financial OfficerSSale−5.00K$14.02−$70.1K−15.7%26.8K after10b5-1
Apr 21, 2023 (view filing)Apr 192 daysAzamian Bobak R.President/CEO and Board ChairSSale−8.00K$13.60−$108.8K−0.7%1.07M after10b5-1
Apr 25, 2023 (view filing)Apr 214 daysAzamian Bobak R.President/CEO and Board ChairSSale−2.31K$15.03−$34.7K−0.2%1.07M after10b5-1
May 2, 2023 (view filing)Apr 28-May 14 daysAzamian Bobak R.President/CEO and Board ChairSSale−10.1K$15.11−$152.9K−0.9%1.06M after2 lots10b5-1
May 12, 2023 (view filing)May 102 daysAzamian Bobak R.President/CEO and Board ChairSSale−9.00K$16.80−$151.2K−0.8%1.05M after10b5-1
May 19, 2023 (view filing)May 172 daysAzamian Bobak R.President/CEO and Board ChairSSale−8.00K$15.90−$127.2K−0.8%1.04M after10b5-1
Jun 8, 2023 (view filing)Jun 6-72 daysMottiwala AzizChief Commercial OfficerSSale−4.64K$19.00−$88.2K−8.8%48.2K after2 lots10b5-1
Jun 12, 2023 (view filing)Jun 84 daysMottiwala AzizChief Commercial OfficerSSale−100$20.00−$2.00K−0.2%48.1K after10b5-1
Jun 12, 2023 (view filing)Jun 84 daysAzamian Bobak R.President/CEO and Board ChairSSale−3.10K$20.01−$62.0K−0.3%1.04M after10b5-1
Jun 16, 2023 (view filing)Jun 142 daysAzamian Bobak R.President/CEO and Board ChairSSale−9.00K$18.58−$167.2K−0.9%1.03M after10b5-1
Jun 23, 2023 (view filing)Jun 212 daysAzamian Bobak R.President/CEO and Board ChairSSale−8.00K$18.63−$149.0K−0.8%1.02M after10b5-1
Jul 14, 2023 (view filing)Jul 122 daysAzamian Bobak R.President/CEO and Board ChairSSale−9.00K$17.35−$156.2K−0.9%1.01M after10b5-1
Jul 21, 2023 (view filing)Jul 192 daysMottiwala AzizChief Commercial OfficerSSale−2.40K$20.05−$48.1K−5.0%45.8K after10b5-1
Jul 21, 2023 (view filing)Jul 192 daysAzamian Bobak R.President/CEO and Board ChairSSale−103.9K$20.01−$2.08M−10.2%910.1K after2 lots10b5-1
Aug 17, 2023 (view filing)Aug 152 daysLin Elizabeth YeuDirectorPPurchase+9.51K$16.80+$159.7K+149.5%15.9K after
Aug 25, 2023 (view filing)Aug 232 daysAzamian Bobak R.President/CEO and Board ChairSSale−8.00K$17.23−$137.8K−0.9%902.1K after10b5-1
Sep 22, 2023 (view filing)Sep 202 daysAzamian Bobak R.President/CEO and Board ChairSSale−8.00K$17.21−$137.7K−0.9%894.1K after10b5-1
Oct 6, 2023 (view filing)Oct 51 dayTrevejo Jose M.CHIEF MEDICAL OFFICERSSale−1.60K$18.00−$28.9K−26.3%4.50K after10b5-1
Oct 20, 2023 (view filing)Oct 182 daysAzamian Bobak R.President/CEO and Board ChairSSale−8.00K$13.24−$105.9K−0.9%886.1K after10b5-1
Nov 17, 2023 (view filing)Nov 152 daysAzamian Bobak R.President/CEO and Board ChairSSale−8.00K$18.37−$146.9K−0.9%878.1K after3 lots10b5-1
Dec 1, 2023 (view filing)Nov 301 dayWhitfield Dianne C.Chief Human Resources OfficerSSale−8.36K$16.31−$136.3K−23.8%26.8K after
Dec 1, 2023 (view filing)Nov 301 dayWahl BryanGeneral CounselSSale−8.36K$16.31−$136.3K−20.7%32.0K after